Alex has transformed medical affairs functions at global pharmaceutical companies by cultivating value through enhanced capabilities and processes.

Alex leads the integrated evidence strategy and planning service line and is also the medical affairs lead for Americas-East. He helps clients deliver a differentiated evidence package to external healthcare stakeholders. Alex also focuses on bringing innovative solutions and building a deep community of experts who can support functional transformation.

Alex enjoys working side-by-side with medical teams to evaluate their overall asset strategy and create the pull-through tactics to close knowledge and data gaps. He has developed numerous medical strategic plans, integrated evidence plans, scientific narratives and field medical deployment scenarios across therapy areas. He has worked on initiatives to support portfolio-level goals, such as launch readiness, external scientific exchange and medical impact measurement. Alex has also leveraged qualitative and quantitative market insights to inform strategic decision-making.

With more than 15 years of experience in life sciences, Alex has consulted on every aspect of commercialization across sales, marketing, access, patient services and medical affairs. He has experience supporting global, U.S. and other ex-U.S. affiliate markets, including Canada, France, Germany and Japan.

Alex holds an MBA from Columbia Business School and a B.S. in applied economics and management from Cornell University.